Press room | News



Dec 15, 2014

Heptares’ Extends Global Patent Protection For GPCR-Focused Drug Discovery Platform With Grant Of Core Patents In The United States

Nov 20, 2014

Heptares Orphan Disease Programme Awarded Grant From The UK Biomedical Catalyst

Nov 17, 2014

Heptares First-In-Class Selective Muscarinic Agonists Chosen As One Of Top Neuroscience Projects To Watch

Sep 16, 2014

Heptares To Present On Structure-based Drug Design Using G Protein-coupled Reception At Inaugural Chemistry & Engineering News Virtual Symposium

Sep 10, 2014

Heptares to present at CNS Partnering & Deal-Making and Biopharm America

Jul 7, 2014

Heptares Announces Publication In Nature Of First Structure Of Metabotropic Glutamate Receptor 5 Transmembrane Domain

Jun 30, 2014

Heptares Chief Scientific Officer And Co-founder Fiona Marshall to Present At Royal Society Of Medicine Medical Innovations Summit

Jun 24, 2014

Heptares To Present At JMP Securities Healthcare Conference

May 29, 2014

Heptares To Present At Jefferies 2014 Global Healthcare Conference And Upcoming Industry And Scientific Events

May 15, 2014

Heptares To Present At UBS Global Healthcare Conference And Upcoming Scientific Events

Apr 16, 2014

Heptares At Upcoming Diabetes And Neuroscience Partnering And Investment Conferences

Mar 26, 2014

Heptares Presentation at Future Leaders in the Biotech Industry to be Webcast

Mar 7, 2014

Heptares To Present At Upcoming Biotech Business Development Events

Jan 23, 2014

Heptares Successfully Completes Research Phase Of Antibody Discovery Collaboration With MedImmune

Jan 9, 2014

Heptares Appoints Tim Tasker As Chief Medical Officer

Jan 8, 2014

Heptares To Moderate Panel On Global Business Development At Upcoming Boston Biotech East/West CEO Conference

Back to top

Other News


© 2012-2014 Heptares Therapeutics